Adma生物制品

ADMA NASDAQ
4.040
-0.030
-0.74%
盘后: 3.900 -0.14 -3.47% 19:58 07/15 EDT
开盘
4.070
昨收
4.070
最高
4.120
最低
3.980
成交量
54.15万
成交均量(3M)
97.50万
52周最高
6.96
52周最低
2.080
换手率
1.20%
市值
1.83亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Adma生物制品 ADMA股票价格,Adma生物制品股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.
展开 >

最近浏览

名称
价格
涨跌幅